Truist Financial Reaffirms Their Hold Rating on Teleflex (TFX)
In a report released today, Richard Newitter from Truist Financial reiterated a Hold rating on Teleflex, with a price target of $143.00.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Newitter covers the Healthcare sector, focusing on stocks such as Insulet, Boston Scientific, and Lantheus. According to TipRanks, Newitter has an average return of 5.9% and a 44.51% success rate on recommended stocks.
In addition to Truist Financial, Teleflex also received a Hold from Mizuho Securities’s Anthony Petrone in a report issued on May 8. However, on the same day, Raymond James maintained a Buy rating on Teleflex (NYSE: TFX).
Based on Teleflex’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $548.26 million and a GAAP net loss of $8.15 million. In comparison, last year the company earned a revenue of $700.67 million and had a net profit of $95 million
Read More on TFX:
